Del Laboratories, Inc. (extinct)

Del Laboratories, Inc. (extinct)

Del Laboratories, Inc. (extinct)

Overview
Date Founded

1961

Headquarters

726 RexCorp Plaza,Uniondale, NY 11556-0726

Type of Company

Private

Industries

Personal Products
Wholesale: Consumer Non-Durables/Sundries
Pharmaceuticals

Company Description

Del Laboratories, Inc. is a leading developer, manufacturer, and marketer of cosmetics and over the counter pharmaceuticals. Its product portfolio is comprised of several market leading brands, including Sally Hansen, La Cross, N.Y.C. New York Color, and Orajel. Del enjoys leadership positions in the nail care, bleaches & depilatories, and oral analgesics categories. Del's market leading positions have been achieved due to the treatment benefits associated with most of its products and its product innovation. Del generates a majority of its revenues from products that are leaders in their respective categories.

In The News
Paths to Del Laboratories, Inc.
Potential Connections via
Relationship Science
You
Del Laboratories, Inc.
Recent Transactions
Details Hidden

Church & Dwight Co., Inc., Kelso & Co. LP, DLI Holding Corp. purchase Del Laboratories, Inc.

Transaction Advisors
Investment Advisor

Advised onChurch & Dwight Co., Inc., Kelso & Co. LP, DLI Holding Corp. purchase Del Laboratories, Inc.

Public Relations

Advised onChurch & Dwight Co., Inc., Kelso & Co. LP, DLI Holding Corp. purchase Del Laboratories, Inc.

Accountant

Advised onChurch & Dwight Co., Inc., Kelso & Co. LP, DLI Holding Corp. purchase Del Laboratories, Inc.

Investment Advisor

Advised onChurch & Dwight Co., Inc., Kelso & Co. LP, DLI Holding Corp. purchase Del Laboratories, Inc.

Attorney

Advised onChurch & Dwight Co., Inc., Kelso & Co. LP, DLI Holding Corp. purchase Del Laboratories, Inc.

Investment Advisor

Advised onChurch & Dwight Co., Inc., Kelso & Co. LP, DLI Holding Corp. purchase Del Laboratories, Inc.

Advisors & Consultants
Legal Advisor

Partner at Cadwalader, Wickersham & Taft LLP

Investors
Details Hidden

Kelso & Co. seeks to realize significant long-term capital gains by investing in equity, equity-related and other securities and obligations of entities undergoing LBOs and recapitalizations and that require capital for operations or business expansion. Kelso's funds primarily pursue investment opportunities in growing middle-market companies across a broad range of industries. The firm is primarily engaged in the purchase of significant ownership of businesses, including private companies, divisions or subsidiaries of public or private companies, public companies through recapitalizations or going private transactions and significant blocks of stock from public or private companies seeking equity capital or persons seeking liquidity. They focus on a variety of sectors including manufacturing, communications & media, distribution & services. consumer & retail, chemicals, healthcare, energy, textiles & apparel and transportation and logistics.Kelso generally seeks control-oriented equity investments in companies led by strong management teams that are responsible for strategic growth and day-to-day company operations. The firm may take minority stakes in companies, typically in conjunction with board representation or other significant shareholders' rights, or may join with other investors as a member of a control group. They do not engage in hostile acquisitions or substantial dismantling or liquidation of companies. Kelso is a long-term investor, typically retaining equity ownership for five to seven years. Ownership values are realized by a number of exit strategies, including public stock offering, recapitalization, sale back to the company, sale to a financial buyer and sale to a corporate buyer.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Del Laboratories, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Del Laboratories, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Del Laboratories, Inc..